
Jason Nideffer
@jasonnideffer
Immunologist @stanfordimmuno studying immune memory to better treat disease—tolerance is key.
ID: 1573895085774712832
25-09-2022 04:40:17
26 Tweet
69 Followers
105 Following

Out on bioRxiv, I'm excited to share our latest deep dive into the world of mitochondrial genetics using single-cell genomics. Grateful to have worked with LeifLudwig, Ansu Satpathy, and many others. biorxiv.org/content/10.110… Thread here: 1/n



We have a new episode out! Dr. Prasanna Jagannathan (Prasanna Jagannathan) from Stanford Medicine talks about the effects of repeated exposure to #malaria and promising vaccines and treatments to prevent reinfection. 🦠 Jagannathan Lab Listen here: bit.ly/44D92Zg

¡Saludos desde Barcelona! (“Greetings from Barcelona!”) 🇪🇸 We’ve been enjoying the incredible community and science at Gordon Research Conferences #GRCMalaria and hope you had a chance to see our posters and talks!


PhD Candidate Jason Nideffer gave a “Science In Progress” talk for Stanford Immunology today full of hot Tr1 takes and interesting data—great job, Jason!


My research team shares lab-space with these 3 immuno-leaders Scott Mueller Mackay Lab Bill Heath Doherty Institute. Interested in joining this energetic community of ~40 immunologists, as a PhD student, RA, or post-doc? Please e-mail me to discuss your ideas & plans.


Fantastic work from Šimon Borna and the Bacchetta lab Stanford Medicine describing Treg instability in patients with IPEX disease! science.org/doi/10.1126/sc…

My team at Doherty Institute are grateful to have been awarded an #NHMRC Ideas grant to work with Teichlab Cambridge University and Prasanna Jagannathan Stanford University on T cell immunity to #malaria. With new team members joining us, it’s time to learn how to manage change in our group!




A huge congratulations 🥳🎊 to Jason Nideffer for successfully defending his thesis today on "The Pediatric CD4+ T Cell Response to Malaria.” #PhD #thesisdefense #StanfordImmunology


Excited to see our work designing novel and effective bispecific antibodies against SARS2 variants published in Science Translational Medicine. Grateful to my co-authors and all who supported the work Christopher Barnes, Ph.D. The Barnes Lab! science.org/doi/10.1126/sc…
